Resmed Inc
NYSE:RMD
Resmed Inc
Cash from Operating Activities
Resmed Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Resmed Inc
NYSE:RMD
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Resmed Inc's Cash from Operating Activities?
Cash from Operating Activities
1.2B
USD
Based on the financial report for Mar 31, 2024, Resmed Inc's Cash from Operating Activities amounts to 1.2B USD.
What is Resmed Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
12%
Over the last year, the Cash from Operating Activities growth was 124%. The average annual Cash from Operating Activities growth rates for Resmed Inc have been 13% over the past three years , 22% over the past five years , and 12% over the past ten years .